Long-acting parathyroid hormone receptor agonist rectifies hypocalcemia in autosomal dominant hypocalcemia type 1 mice.
Hannan FM., Stevenson M., Elajnaf T., Rostom H., Lines KE., Stewart M., Wells S., Moir L., Gardella TJ., Thakker RV.
Eneboparatide, a long-acting modified form of parathyroid hormone, increases serum calcium levels without increasing urine calcium in mice with autosomal dominant hypocalcemia type 1.